Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Expands By 201.6%

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 281,498 shares, an increase of 201.6% from the May 31st total of 93,339 shares. Approximately 34.5% of the company’s stock are sold short. Based on an average trading volume of 321,156,604 shares, the days-to-cover ratio is presently 0.0 days.

Insider Activity

In other news, major shareholder Financial Lp Hrt sold 3,132,480 shares of Aditxt stock in a transaction that occurred on Tuesday, June 16th. The shares were sold at an average price of $0.01, for a total transaction of $31,324.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders have sold a total of 3,260,940 shares of company stock worth $45,518 in the last 90 days. Company insiders own 0.01% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Wall Street Zen raised shares of Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings downgraded Aditxt from a “sell (e+)” rating to a “sell (e)” rating in a research note on Wednesday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aditxt currently has an average rating of “Sell”.

Aditxt Stock Up 19.0%

NASDAQ:ADTX traded up $0.00 during trading hours on Monday, reaching $0.00. 77,287,593 shares of the stock were exchanged, compared to its average volume of 125,620,891. Aditxt has a 52 week low of $0.00 and a 52 week high of $33,438.96. The stock has a market capitalization of $2,040.00, a P/E ratio of -0.00 and a beta of 0.84. The firm has a 50 day simple moving average of $2.43 and a 200-day simple moving average of $99.72.

Aditxt (NASDAQ:ADTX) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.